Drug Cost Trends In 2024 Are ‘Nearly Unprecedented,’ Research Finds

Drugmakers aren’t raising prices like they used to, according to data from 46brooklyn Research.

On Jan. 1, 453 branded drugs increased in cost — a similar figure to the start of 2023, which saw 452 pricier brand-name drugs. Drugmakers typically make the most drug price changes in January, and in 2023 and 2024, there seems to be a downward trend.

In 2022, there were 540 drug price increases, and the year before, 46brooklyn Research recorded 602.

Not only are there fewer brand-name drugs with bigger price tags this year, but 24 products became cheaper on Jan. 1.

“That number is nearly unprecedented,” 46brooklyn Research said in a Jan. 12 news release. “In our dashboard — which tracks price change activity back to 2012 — no day has ever had that many brand list price decreases (let alone the first day of the year — a time we typically associate with increases).”

Halfway through January, drugmakers have increased prices for about 600 medications. 46brooklyn’s CEO, Antonio Ciaccia, told NPR he expects a few hundred more drug price increases before the end of the month.

But, Mr. Ciaccia added, the price decreases are nearly canceling out the price hikes.

“In the landscape of drug pricing, the year 2024 presents a noteworthy departure from the norm, marking a significant shift in the statistical trends,” the release said.

 

Source Link

Recommended Articles

GOP Takes Aim At Hospital CEOs Over Affordability Crisis

House Republicans during a Tuesday hearing blamed hospital and health systems for high health costs, excoriating a group of CEOs for exorbitant benefits packages, large profit margins and mergers. “Our communities are better off with hospitals in them, but large health systems have taken advantage of that reality,” Ways and Means Committee chairman Jason Smith (R-Mo.) said. “Simply put, hospitals are charging an insane amount for care.” ...

Read More

Hospital CEOs Defend Charging Patients More At Facilities

Hospital CEOs came under fire at a House hearing Tuesday, with Republicans accusing them of overcharging patients and exploiting the system. Executives from HCA Healthcare, CommonSpirit Health, New York-Presbyterian and ECU Health testified before the House Ways and Means Committee, defending their pricing practices — including that they should be able to charge higher prices for the same services ...

Read More

Humana Pulls Back The Curtain On Planning For 2027 MA Bids

Humana executives gave investors a peek Wednesday into the company’s thinking around the 2027 Medicare Advantage bid cycle as elevated costs continue to sting the industry. CEO Jim Rechtin said during the insurer’s earnings call that to achieve the goal of returning to a “stable margin” by 2028, it will need to look at adjustments ...

Read More

Health Costs Still A Top Voter Concern, Poll Finds

Health costs continue to top the public’s list of affordability worries, and while Democrats have an edge over Republicans, both parties need to do more to convince independents, according to a new poll from health policy research group KFF. About nine in 10 voters said the issue of health costs will influence their decision to vote and who to vote for in ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square